Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ELIQUIS vs EMAPALUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ELIQUIS vs EMAPALUMAB: Safety Overview

Metric ELIQUIS EMAPALUMAB
Total FAERS Reports 1,430 173
Deaths Reported 98 63
Death Rate 6.9% 36.4%
Hospitalizations 273 84
Average Patient Age 76.5 yrs 17.1 yrs
% Female Patients 100.0% 48.7%
Manufacturer N/A Swedish Orphan Biovitrum AB (publ)
Route N/A INTRAVENOUS